
Pathology Instruments Market by Product Type (Cytology Equipment, Digital Pathology Systems, Hematology Instruments), Type of Test (Clinical Chemistry, Cytology, Hematology), Application, End-User - Global Forecast 2023-2030
Description
Pathology Instruments Market by Product Type (Cytology Equipment, Digital Pathology Systems, Hematology Instruments), Type of Test (Clinical Chemistry, Cytology, Hematology), Application, End-User - Global Forecast 2023-2030
The Pathology Instruments Market size was estimated at USD 5.61 billion in 2022 and expected to reach USD 5.92 billion in 2023, at a CAGR 5.37% to reach USD 8.53 billion by 2030.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Pathology Instruments Market.
- Based on Product Type, market is studied across Cytology Equipment, Digital Pathology Systems, Hematology Instruments, Image Analysis Software, Immunohistochemistry (IHC) Instruments, Microtomes, Slide Stainers, Special Stains, and Tissue Processors. The Cytology Equipment is projected to witness significant market share during forecast period.
- Based on Type of Test, market is studied across Clinical Chemistry, Cytology, Hematology, Histology, Microbiology, and Molecular Diagnostics. The Cytology is projected to witness significant market share during forecast period.
- Based on Application, market is studied across Disease Diagnostics, Drug Discovery and Development, and Forensic Diagnostics. The Drug Discovery and Development is projected to witness significant market share during forecast period.
- Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories, Hospitals, and Pharmaceutical & Biotechnology. The Contract Research Organizations (CROs) is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Pathology Instruments Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Pathology Instruments Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Pathology Instruments Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio SB, Bio-Genex Laboratories, Bio-Rad Laboratories, Inc., BrandTech Scientific, Inc., Danaher Corporation, Diapath S.p.A., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, GPC Medical Ltd., Hamamatsu Photonics K.K., Leica Biosystems Nussloch GmbH, Liberty Industries, Inc., Merck KGaA, Mikroscan Technologies, Inc., PerkinElmer Inc., PHC Holdings Corporation, QIAGEN GmbH, Sakura Finetek USA, Inc., Shimadzu Corporation, Siemens Healthineers, Thermo Fisher Scientific Inc., and Waters Corporation.
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Pathology Instruments Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Pathology Instruments Market?
- What is the competitive strategic window for identifying opportunities in the Pathology Instruments Market?
- What are the latest technology trends and regulatory frameworks in the Pathology Instruments Market?
- What is the market share of the leading vendors in the Pathology Instruments Market?
- Which modes and strategic moves are suitable for entering the Pathology Instruments Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
194 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Pathology Instruments Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. High prevalence of chronic diseases worldwide
- 5.1.1.2. Increasing molecular biology's role for personalized medicine
- 5.1.1.3. Inclination toward digital pathology solutions
- 5.1.2. Restraints
- 5.1.2.1. Instrument-related errors and potential accuracy issues
- 5.1.3. Opportunities
- 5.1.3.1. Significant efforts toward drug discovery & development
- 5.1.3.2. Innovation in pathology instruments
- 5.1.4. Challenges
- 5.1.4.1. Lack of standards and skilled workforce
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Pathology Instruments Market, by Product Type
- 6.1. Introduction
- 6.2. Cytology Equipment
- 6.3. Digital Pathology Systems
- 6.4. Hematology Instruments
- 6.5. Image Analysis Software
- 6.6. Immunohistochemistry (IHC) Instruments
- 6.7. Microtomes
- 6.8. Slide Stainers
- 6.9. Special Stains
- 6.10. Tissue Processors
- 7. Pathology Instruments Market, by Type of Test
- 7.1. Introduction
- 7.2. Clinical Chemistry
- 7.3. Cytology
- 7.4. Hematology
- 7.5. Histology
- 7.6. Microbiology
- 7.7. Molecular Diagnostics
- 8. Pathology Instruments Market, by Application
- 8.1. Introduction
- 8.2. Disease Diagnostics
- 8.3. Drug Discovery and Development
- 8.4. Forensic Diagnostics
- 9. Pathology Instruments Market, by End-User
- 9.1. Introduction
- 9.2. Academic & Research Institutes
- 9.3. Contract Research Organizations (CROs)
- 9.4. Diagnostic Laboratories
- 9.5. Hospitals
- 9.6. Pharmaceutical & Biotechnology
- 10. Americas Pathology Instruments Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Pathology Instruments Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Pathology Instruments Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories
- 14.1.2. Agilent Technologies, Inc.
- 14.1.3. Becton, Dickinson and Company
- 14.1.4. Bio SB
- 14.1.5. Bio-Genex Laboratories
- 14.1.6. Bio-Rad Laboratories, Inc.
- 14.1.7. BrandTech Scientific, Inc.
- 14.1.8. Danaher Corporation
- 14.1.9. Diapath S.p.A.
- 14.1.10. F. Hoffmann-La Roche AG
- 14.1.11. Fujifilm Holdings Corporation
- 14.1.12. GPC Medical Ltd.
- 14.1.13. Hamamatsu Photonics K.K.
- 14.1.14. Leica Biosystems Nussloch GmbH
- 14.1.15. Liberty Industries, Inc.
- 14.1.16. Merck KGaA
- 14.1.17. Mikroscan Technologies, Inc.
- 14.1.18. PerkinElmer Inc.
- 14.1.19. PHC Holdings Corporation
- 14.1.20. QIAGEN GmbH
- 14.1.21. Sakura Finetek USA, Inc.
- 14.1.22. Shimadzu Corporation
- 14.1.23. Siemens Healthineers
- 14.1.24. Thermo Fisher Scientific Inc.
- 14.1.25. Waters Corporation
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.